About
Female
Alexandra Glucksmann is the Chief Executive Officer and President. She previously worked at Cedilla Therapeutics as a President and CEO. Alexandra Glucksmann attended the University of Chicago.
Experience
Adjuvant Capital
View →Investment Committee Member · 2023 – present
31New York, New York, United StatesFinancial Services · Health Care
- President and Chief Executive Officer · Sensorium Therapeutics2023 – present
- Scientific Advisor · EdiTy Therapeutics2022 – present
- Independent Board Member · REGENXBIO2018 – present
- Independent Board Member · Scenic Biotech2017 – present
Education
- Massachusetts Institute of Technology · Post-doctoral fellow, Molecular Biology1990 – 1993
- University of Chicago · PhD, Molecular Genetics and Cell Biology1983 – 1989
People at Adjuvant Capital
Data from: crunchbase
